Pituitary DiseasesNCT00473369
Prognosis of Atypical Pituitary Adenomas
An observational study of Pituitary Diseases, run by Tohoku University.
Trial summary
Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology. Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Read more about this study
- Who is it for?
- Ages 12 to 74 years
- Conditions the study is for
- Pituitary Diseases
- How many people
- Not given
- Where
- No sites listed yet
- Study dates
- Jan 2001to May 2007
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 74 years
- All sexes
- Child, Adult, Older adult
Who may be able to join
- pituitary adenomas of more than 3 % of Ki67 labeling index surgically treated at Tohoku university and associated hospital
Who cannot join
- pituitary adenomas of less than 3 % of Ki-67 labeling index surgically treated at Tohoku university and associated hospital
About this study
Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology.
Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Setting: University and associated hospitals.
- Conditions
- Pituitary Diseases
- Keywords
- atypical adenoma, Ki-67, p53, pituitary, prognosis
- Medical subject headings
- Pituitary Diseases
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 May 2007 (estimated)
- Study startJan 2001
- Study completionMay 2007 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pituitary DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Other
Sponsor and investigators
- Lead sponsor
- Tohoku University
- Sponsor type
- University, hospital or other
- Investigators
- Yoshikazu Ogawa, M. D., Principal investigator, Department of neurosurgery, Tohoku university
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00473369
- Sponsor's protocol ID
- 1-2007.nsg.med.tohoku
- Status last verified
- May 2007
- First submitted
- 14 May 2007
- Last updated
- 15 May 2007
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 15 May 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prognosis of Atypical Pituitary Adenomas
- ClinicalTrials.gov ID
- NCT00473369
- Acronym / sponsor ID
- 1-2007.nsg.med.tohoku
- Conditions
- Pituitary Diseases
- Keywords
- atypical adenoma, Ki-67, p53, pituitary, prognosis
- Study type
- Observational
- Recruitment status
- Unknown status
- Lead sponsor
- Tohoku UniversityUniversity, hospital or other
- Study start
- Jan 2001
- Study completion
- May 2007 (estimated)
- First posted
- 15 May 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology.
Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Setting: University and associated hospitals.
Study design
- Observational model
- Case-control
- Time perspective
- Other
Who may qualify
- Ages
- 12 to 74 years
- Sex
- All
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- pituitary adenomas of more than 3 % of Ki67 labeling index surgically treated at Tohoku university and associated hospital
Key exclusion criteria (1 listed)
- pituitary adenomas of less than 3 % of Ki-67 labeling index surgically treated at Tohoku university and associated hospital
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 May 2007.
Related trials for Pituitary Diseases
RecruitingPhase 2
Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery
Pain, Pituitary Surgery
RecruitingObservational study
Evaluation and Treatment of Neurosurgical Disorders
Neurologic Disorders
RecruitingPhase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Turner Syndrome, Short Stature Homeobox Gene Mutation
RecruitingObservational study
Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)
Cushing s Syndrome, Cushing Disease
RecruitingPhase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Functional Hypothalamic Amenorrhea, FHA
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yoshikazu Ogawa, M. D. principal investigator
Department of neurosurgery, Tohoku university
Questions about this trial
What is this clinical trial studying?
An observational study of Pituitary Diseases, run by Tohoku University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 15 May 2007. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2007.